PUBLICATIONS |
1 |
F. Torre, F. Mattioli, N. Campo, A. Delfino,
M. Basso, N. Peli, A. Martelli, A. Picciotto. Serum lamivudine levels
in the presence of a lamivudine-resistant HBV mutant. Digestive
and Liver Disease 36: 677-681, 2004. |
2 |
I. Vezzana, E. Terranova, F. Mattioli, F. Sparatore.
Aromatic Schiff bases and 2,3-disubstituted-1,3-thiazolidin-4-one
derivatives as antiinflammatory agents. Arkivoc: 364-374, 2004. |
3 |
L. Robbiano, A. Martelli, G. Brambilla. The
questionable use of antihypertensive drugs in the Italian Liguria
region in the year 2003. Eur. J. Clin. Pharmacol. 61: 319-320, 2005.
|
4 |
F. Mattioli, A. Martelli, C. Garbero, M. Gosmar,
V. Manfredi, F.P. Mattioli, G. Torre, G. Brambilla. DNA fragmentation
and DNA repair synthesis induced in rat and human thyroid cells
by four rat thyroid carcinogens. Toxicology and Appl. Pharm. 203:
99-105, 2005. |
5 |
G. Brambilla, A. Martelli. Keynote comment:
nitrosatable drugs, cancer, and guidelines for genotoxicity. The
Lancet Oncology, v. 6: 538-539, 2005. |
6 |
L. Robbiano. A. Martelli, G. Brambilla. Discrepancies
between use of antihypertensive drugs and guidelines indications:
pharmacoeconomic implications. Journal of Human Hypertension 19:
819-822, 2005. |
7 |
F. Mattioli, A. Curotto, V. Manfredi, M. Gosmar,
C. Garbero, C. Ambruosi, G. Carmignani, A. Martelli. Intravescical
Gemcitabine in Superficial Bladder Cancer: a Phase II Safety, Efficacy
and Pharmacokineticl Study. Anticancer Res. 25: 2493-2496, 2005. |
|